Cyclocreatine

DB17624ExperimentalSmall molecule

Cyclocreatine: Overview.

Mechanism: Pharmacologically active on Creatine kinase B-type and Creatine Kinases
Curator reviewed
Formula / weight: C₅H₉N₃O₂ · 143.146 g/mol (avg)
Also known as: 1-carboxymethyl-2-imino-imidazolidine · 2-imino-1-imidazolidineacetic acid
Code names: AM-285 · NSC-707961

Resolves to

Compound

UNII6732XGX1RKCAS35404-50-3ChEMBLCHEMBL179900

Structure

InChIKeyAMHZIUVRYRVYBA-UHFFFAOYSA-NSMILESOC(=O)CN1CCNC1=N

Targets

P12277CKB

Transporters

P48029SLC6A8Q7RTY1SLC16A9

What you can answer from here — as of September 12, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2TransportersSubstrate / inhibitor direction, not just membership

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cyclocreatine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In